Alterations in ABPs expression levels were also noted by Latham and colleagues, who defined ACTB-AST, a new clinical entity manifested by microcephaly, intellectual disability, minor facial anomalies, white blood cell anomalies and thrombocytopenia caused by mutations clustered in the 3′ region of ACTB [39]. This evidence concerns the gene ACTB and Thrombocytopenia.